Halozyme Therapeutics
HALO
New Fortress Energy
NFE
DexCom
DXCM
4
YETI Holdings
YETI
5
Teradata Corp
TDC
(Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | |
---|---|---|---|---|---|---|---|---|---|---|
Assets | ||||||||||
Cash cash equivalents and federal funds sold | 33.94%159.71M | 28.07%100.66M | 28.07%100.66M | 49.98%132.8M | 77.80%183.99M | 42.80%119.24M | 1.91%78.6M | 1.91%78.6M | 2.14%88.54M | -36.07%103.48M |
-Cash and cash equivalents | 33.94%159.71M | 28.07%100.66M | 28.07%100.66M | 49.98%132.8M | 77.80%183.99M | 42.80%119.24M | 1.91%78.6M | 1.91%78.6M | 2.14%88.54M | -36.07%103.48M |
Receivables | ---- | -21.37%16M | -21.37%16M | ---- | ---- | ---- | 10.86%20.35M | 10.86%20.35M | ---- | ---- |
-Accounts receivable | ---- | -21.37%16M | -21.37%16M | ---- | ---- | ---- | 10.86%20.35M | 10.86%20.35M | ---- | ---- |
Net loan | 6.83%2.28B | 11.46%2.33B | 11.46%2.33B | 10.61%2.3B | 6.84%2.21B | 6.12%2.13B | 1.81%2.09B | 1.81%2.09B | 4.09%2.08B | 3.64%2.07B |
-Gross loan | 6.95%2.31B | 11.41%2.36B | 11.41%2.36B | 10.46%2.32B | 6.69%2.23B | 6.04%2.16B | 1.79%2.12B | 1.79%2.12B | 3.98%2.1B | 3.55%2.09B |
-Allowance for loans and lease losses | 16.90%27.05M | 5.66%24.83M | 5.66%24.83M | -1.52%22.71M | -5.95%21.64M | 0.22%23.14M | 1.91%23.5M | 1.91%23.5M | -3.07%23.06M | 0.91%23.01M |
-Unearned income | -146.26%-99K | -69.90%93K | -69.90%93K | 142.94%396K | 294.52%288K | 791.67%214K | 351.22%309K | 351.22%309K | 146.84%163K | 106.75%73K |
Securities and investments | -12.83%922.41M | -27.09%986.93M | -27.09%986.93M | -23.89%1.02B | -24.07%1.03B | -22.96%1.06B | 5.60%1.35B | 5.60%1.35B | 8.83%1.33B | 32.22%1.36B |
-Available for sale securities | --159.3M | 76.85%25.45M | 76.85%25.45M | ---- | ---- | ---- | 43.17%14.39M | 43.17%14.39M | ---- | ---- |
-Held to maturity securities | -4.51%302.12M | -4.54%305.51M | -4.54%305.51M | -4.50%308.97M | -4.75%312.88M | -4.91%316.41M | -4.99%320.06M | -4.99%320.06M | 107.12%323.54M | 103.52%328.48M |
-Short term investments | -37.85%460.99M | -35.64%655.97M | -35.64%655.97M | -30.09%706.31M | -30.24%716.79M | -28.74%741.79M | 9.01%1.02B | 9.01%1.02B | -5.52%1.01B | 18.90%1.03B |
Long term equity investment | ---- | 0.00%4.36M | 0.00%4.36M | ---- | ---- | ---- | 0.00%4.36M | 0.00%4.36M | ---- | ---- |
Federal home loan bank stock | ---- | 0.13%14.68M | 0.13%14.68M | ---- | ---- | ---- | 15.15%14.66M | 15.15%14.66M | ---- | ---- |
Bank owned life insurance | -0.61%52.66M | 3.07%53.15M | 3.07%53.15M | 5.20%54M | 1.34%53.43M | 1.28%52.98M | -1.14%51.57M | -1.14%51.57M | -1.55%51.33M | 1.09%52.73M |
Net PPE | -4.54%15.34M | -9.87%15.24M | -9.87%15.24M | -28.64%15.65M | -27.48%16.01M | -28.02%16.07M | -24.78%16.91M | -24.78%16.91M | -3.36%21.93M | -3.77%22.07M |
-Gross PPE | ---- | -2.66%45.91M | -2.66%45.91M | ---- | ---- | ---- | -20.96%47.17M | -20.96%47.17M | ---- | ---- |
-Accumulated depreciation | ---- | -1.37%-30.68M | -1.37%-30.68M | ---- | ---- | ---- | 18.64%-30.26M | 18.64%-30.26M | ---- | ---- |
Goodwill and other intangible assets | -2.54%27.81M | -2.72%27.98M | -2.72%27.98M | -5.58%27.36M | -3.00%28.32M | -2.98%28.54M | -2.96%28.76M | -2.96%28.76M | -3.01%28.98M | -3.09%29.19M |
-Goodwill | 0.00%27.36M | 0.00%27.36M | 0.00%27.36M | 0.00%27.36M | 0.00%27.36M | 0.00%27.36M | 0.00%27.36M | 0.00%27.36M | 0.00%27.36M | 0.00%27.36M |
-Other intangible assets | -61.36%456K | -55.83%618K | -55.83%618K | ---- | -47.69%961K | -42.61%1.18M | -38.51%1.4M | -38.51%1.4M | -35.72%1.62M | -33.66%1.84M |
Other assets | 3.14%148.64M | 1.53%41M | 1.53%41M | 12.10%152.76M | 22.82%156.61M | 18.24%144.11M | 100.50%40.39M | 100.50%40.39M | 14.48%136.27M | 21.24%127.52M |
Total assets | 1.49%3.61B | -3.10%3.61B | -3.10%3.61B | -1.14%3.7B | -2.16%3.68B | -3.81%3.55B | 3.36%3.73B | 3.36%3.73B | 5.85%3.74B | 10.77%3.76B |
Liabilities | ||||||||||
Total deposits | 0.10%2.85B | 4.72%2.89B | 4.72%2.89B | 3.22%2.96B | 0.81%2.94B | -3.46%2.85B | -2.98%2.76B | -2.98%2.76B | -0.55%2.87B | 2.38%2.92B |
Federal funds purchased and securities sold under agreement to repurchase | -2.54%118.76M | -54.09%108.86M | -54.09%108.86M | 32.33%125.53M | 100.76%148M | 29.54%121.85M | 117.21%237.12M | 117.21%237.12M | -15.31%94.87M | -37.53%73.72M |
Current debt and capital lease obligation | ---- | --0 | --0 | --0 | --0 | --0 | -31.28%150.5M | -31.28%150.5M | 129.87%237M | --245.2M |
-Current debt | ---- | --0 | --0 | --0 | --0 | --0 | -31.28%150.5M | -31.28%150.5M | 129.87%237M | --245.2M |
Long term provisions | 51.85%820K | 39.22%710K | 39.22%710K | ---- | -30.67%520K | -36.47%540K | -39.29%510K | -39.29%510K | -36.17%600K | -16.01%750K |
Long term debt and capital lease obligation | 0.16%165.3M | 0.16%165.23M | 0.16%165.23M | 0.16%165.17M | 0.16%165.1M | 94.70%165.03M | 94.77%164.96M | 94.77%164.96M | 94.84%164.9M | 94.91%164.83M |
-Long term debt | 0.16%165.3M | 0.16%165.23M | 0.16%165.23M | 0.16%165.17M | 0.16%165.1M | 94.70%165.03M | 94.77%164.96M | 94.77%164.96M | 94.84%164.9M | 94.91%164.83M |
Other liabilities | 62.70%119.67M | 16.95%90.5M | 16.95%90.5M | 34.41%84.6M | 51.49%75.15M | 77.18%73.55M | 71.43%77.38M | 71.43%77.38M | 23.25%62.94M | 15.06%49.61M |
Total liabilities | 1.45%3.25B | -3.97%3.26B | -3.97%3.26B | -2.70%3.34B | -3.52%3.33B | -5.28%3.21B | 2.62%3.39B | 2.62%3.39B | 5.96%3.43B | 11.47%3.45B |
Shareholders'equity | ||||||||||
Share capital | -2.76%106.28M | -1.34%108.97M | -1.34%108.97M | -1.10%108.44M | -1.97%107.93M | -2.24%109.3M | -2.20%110.45M | -2.20%110.45M | -2.21%109.64M | -1.46%110.1M |
-common stock | -2.76%106.28M | -1.34%108.97M | -1.34%108.97M | -1.10%108.44M | -1.97%107.93M | -2.24%109.3M | -2.20%110.45M | -2.20%110.45M | -2.21%109.64M | -1.46%110.1M |
Paid-in capital | -8.02%4.43M | -1.57%4.51M | -1.57%4.51M | 6.67%5.26M | 9.19%5.34M | 5.57%4.82M | 10.44%4.58M | 10.44%4.58M | 10.38%4.93M | 6.59%4.89M |
Retained earnings | 2.67%269.93M | 6.19%275.09M | 6.19%275.09M | 6.78%273.58M | 6.51%267.48M | 6.56%262.91M | 6.57%259.05M | 6.57%259.05M | 6.98%256.2M | 7.69%251.12M |
Gains losses not affecting retained earnings | 9.53%-28.88M | 13.13%-31.26M | 13.13%-31.26M | 53.85%-28.58M | 45.63%-30.72M | 43.07%-31.92M | 36.40%-35.98M | 36.40%-35.98M | -1.49%-61.91M | -12.03%-56.51M |
Total stockholders'equity | 1.93%351.76M | 5.68%357.3M | 5.68%357.3M | 16.14%358.7M | 13.06%350.02M | 12.40%345.09M | 11.37%338.1M | 11.37%338.1M | 4.67%308.86M | 3.53%309.59M |
Total equity | 1.93%351.76M | 5.68%357.3M | 5.68%357.3M | 16.14%358.7M | 13.06%350.02M | 12.40%345.09M | 11.37%338.1M | 11.37%338.1M | 4.67%308.86M | 3.53%309.59M |
Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
Audit Opinions | -- | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- | -- | -- |